top of page
.png)
Aanika Dalal
Admin
More actions
Profile
Join date: Oct 6, 2023
Posts (8)
May 7, 2026 ∙ 5 min
Introducing ARMoR's Access Program
We have lifesaving antibiotics that are cheap, effective, and have existed for decades. They still fail to reach the patients who most need them. The antibiotic that would have saved a child's life might be: Not registered in their country. Registered, but caught in a supply chain disruption somewhere Manufactured and supplied, but missing from the national formulary or excluded by the procurement system. Procured, but unaffordable to a family paying out of pocket. Stocked, but degraded in...
77
0
Aug 23, 2025 ∙ 11 min
Review of the Council's position on the Transferable Exclusivity Vouchers
Summary Recently, the Council agreed on its position on the Reform of the EU General Pharmaceutical Legislation , setting the stage for...
311
0
Jun 2, 2025 ∙ 11 min
Integrating equitable access conditions into antimicrobial R&D incentive mechanisms
During the 2024 UN High-Level Meeting on Antimicrobial Resistance (AMR), stakeholders set an ambitious goal to achieve a 10% reduction in...
392
0
bottom of page